1997PubMedRequires access

Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.

Christian Schmidt, B Baumeister, J Kipnowski, B. Schiermeyer-Dunkhase, H. Vetter

Open publisher page 15 citations

Abstract

BACKGROUND: Eicosanoid mediators play an important role in the pathogenesis of chronic inflammatory bowel disease. MATERIALS AND METHODS: The synthesis of prostaglandin E2 and leukotriene B4 in biopsied colonic specimens from patients with inflammatory bowel disease was compared with that from healthy controls. In contrast to surgical resection, biopsy by colonoscopy enabled patients with milder disease to be investigated. RESULTS: In subjects with Crohn's disease or ulcerative colitis, the synthesis of PGE2 was significantly (p < 0.05) increased, whereas synthesis of LTB4 remained unaltered. In addition, no differences in PGE2 and LTB4 production were found in different age groups or sex. CONCLUSION: We conclude that prostaglandin E2, compared to leukotriene B4, is the dominant eicosanoid in moderate inflammatory bowel disease.

About this research paper

What this paper is about

BACKGROUND: Eicosanoid mediators play an important role in the pathogenesis of chronic inflammatory bowel disease. MATERIALS AND METHODS: The synthesis of prostaglandin E2 and leukotriene B4 in biopsied colonic specimens from patients with inflammatory bowel disease was compared with that from healthy controls. In contrast to surgical resection, biopsy by colonoscopy enabled patients with milder disease to be investigated. RESULTS: In subjects with Crohn's disease or ulcerative colitis, the synthesis of PGE2 was significantly (p < 0.05) increased, whereas synthesis of LTB4 remained unaltered. In addition, no differences in PGE2 and LTB4 production were found in different age groups or sex. CONCLUSION: We conclude that prostaglandin E2, compared to leukotriene B4, is the dominant eicosanoid in moderate inflammatory bowel disease.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

BACKGROUND: Eicosanoid mediators play an important role in the pathogenesis of chronic inflammatory bowel disease. MATERIALS AND METHODS: The synthesis of prostaglandin E2 and leukotriene B4 in biopsied colonic specimens from patients with inflammatory bowel disease was compared with that from healthy controls. In contrast to surgical resection, biopsy by colonoscopy enabled patients with milder disease to be investigated. RESULTS: In subjects with Crohn's disease or ulcerative colitis, the synthesis of PGE2 was significantly (p < 0.05) increased, whereas synthesis of LTB4 remained unaltered. In addition, no differences in PGE2 and LTB4 production were found in different age groups or sex. CONCLUSION: We conclude that prostaglandin E2, compared to leukotriene B4, is the dominant eicosanoid in moderate inflammatory bowel disease.

Key concepts: Leukotriene B4, Eicosanoid, Inflammatory bowel disease, Prostaglandin E2, Pathogenesis, Medicine, Ulcerative colitis, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease. — Research Paper | ScholarLens